Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

Krabbe Disease Gene Therapy Receives Second Orphan Drug Designation

Posted on October 7, 2021 (June 1, 2022) by Forge Biologics
0/5 (0 Reviews)
Posted in Biologics News, In the news

Post navigation

 Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal CordForge Biologics to Present at 2021 Cell & Gene Meeting on the Mesa 
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree